tafenoquine 150 MG Oral Tablet [Krintafel]
tafenoquine
RxCUI: 2109239
What the CMS Formulary Data Shows for tafenoquine 150 MG Oral Tablet [Krintafel]
Per the CMS 2026 Part D formulary file, tafenoquine 150 MG Oral Tablet [Krintafel] (RxNorm concept RXCUI 2109239, generic name tafenoquine) appears on 17 distinct formulary files spanning 206 Medicare Part D plan offerings - 4.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 4, with a cross-plan average of Tier 3.5.
Real-world access to tafenoquine 150 MG Oral Tablet [Krintafel] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 23.5% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 20 Part D beneficiaries filled tafenoquine 150 MG Oral Tablet [Krintafel] in 2023, with total plan-and-beneficiary spending of $2,874 and an average per-beneficiary annual cost of $143.72. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tafenoquine 150 MG Oral Tablet [Krintafel] today.
Coverage Details
- Formularies covering
- 17
- Plans covering
- 206
- Coverage rate
- 4.1%
- Tier range
- Tier 2 – Tier 4
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 23.5% of formularies
2023 Medicare Spending
- Beneficiaries
- 20
- Total spending
- $2,874
- Avg per beneficiary
- $143.72
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering tafenoquine 150 MG Oral Tablet [Krintafel]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is tafenoquine 150 MG Oral Tablet [Krintafel] covered by Medicare Part D?
Yes, tafenoquine 150 MG Oral Tablet [Krintafel] is covered by 206 Medicare Part D plans (4.1% of all Part D formularies).
What tier is tafenoquine 150 MG Oral Tablet [Krintafel] on Medicare Part D plans?
tafenoquine 150 MG Oral Tablet [Krintafel] averages Tier 3.5 across Part D plans, ranging from Tier 2 to Tier 4.
Does tafenoquine 150 MG Oral Tablet [Krintafel] require prior authorization?
0% of Part D formularies require prior authorization for tafenoquine 150 MG Oral Tablet [Krintafel]. Step therapy: 0%. Quantity limits: 23.5%.
How much does Medicare spend on tafenoquine 150 MG Oral Tablet [Krintafel]?
In 2023, total Medicare Part D spending on tafenoquine 150 MG Oral Tablet [Krintafel] was $2,874, covering 20 beneficiaries. The average spend per beneficiary was $143.72.
Read our methodology - how this data is sourced, computed, and verified.